Thomas Hansen
Promovendus
- Naam
- T. Hansen MSc
- Telefoon
- +31 71 527 4481
- t.hansen@lic.leidenuniv.nl
Promovendus
- Wiskunde en Natuurwetenschappen
- Leiden Institute of Chemistry
- LIC/Bio-organic Synthesis
- Beenakker T.J.M., Wander D.P.A., Offen W.A., Artola Perez de Azanza M.E., Raich L., Guimaraes Da Lomba Ferraz M.J., Li K.Y., Houben J.H.P.M., Rijssel E.R. van, Hansen T., Marel G.A. van der, Codee J.D.C., Aerts J.M.F.G., Rovira C., Davies G.J. & Overkleeft H.S. (2017), Carba-cyclophellitols Are Neutral Retaining-Glucosidase Inhibitors, Journal of the American Chemical Society 139(19): 6534-6537.
- Hagen B., Vorm S. van der, Hansen T., Marel G.A. van der & Codée J.D.C. (2017), Stereoselective glycosylations - Additions to oxocarbenium ions. In: Bennett C. (red.) Selective Glycosylations – Synthetic Methods and Catalysts.: Wiley.
- Vorm S. van der, Hansen T., Overkleeft H.S., Marel G.A. van der & Codee J.D.C. (2017), The Influence of Acceptor Nucleophilicity on the Glycosylation Reaction Mechanism, Chemical Science 2017(8): 1867-1875.
- Mukhopadhyay P., Baggelaar M., Erdelyi K., Cao Z., Cinar R., Fezza F., Ignatowska-Jankowska B., Wilkerson J., Gils N. van, Hansen T., Ruben M., Soethoudt M., Heitman L., Kunos G., Maccarrone M., Lichtman A., Pacher P. & Stelt M. van der (2016), The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity, British Journal of Pharmacology 173(3): 446–458.
Geen relevante nevenwerkzaamheden